Boy Mom Melissa Joan Hart & Her Two Sons Took ‘Cold Plunging to the Next Level' in Rare Family Photo
On May 30, the Sabrina the Teenage Witch star shared a sweet vacay photo on her Instagram with the caption reading, 'Taking cold plunging to the next level! #Laketahoe.'
More from SheKnows
Wayne Gretzky's Daughter Paulina Solidifies Style Icon Status With a Springtime Version of an LBD
In the photo, we see Hart in a one-piece with two of her sons, all of whom are in Lake Tahoe. Fun fact: Lake Tahoe has famously cold waters, making it a go-to for cold plunge therapy. Per Mayo Clinic, cold plunge therapy is when you submerge yourself in cold water for a few minutes to help reduce inflammation, boost mood, and improve circulation.
The family that cold plunges together, stays together. That's how that goes, right?
For those who don't know, Hart and musician Mark Wilkerson married in 2003 after one year of dating. They later welcomed three sons named: Mason, born in Jan 2006, Braydon, born in March 2008, and Tucker, born in Sept 2012.
In a previous chat with SheKnows at the Variety Power of Women in 2024, she spoke about being a mom to three boys. 'Three boys can be a little overwhelming…There are some tough moments, but I wouldn't trade it for anything in the world because it's the greatest job I've ever had,' she said to us.Best of SheKnows
19 Celebrity Parents With Trans & Nonbinary Kids
20 of Serena Williams' Most Adorable Motherhood Moments
30+ Baby Names With Ivy League Vibes — No Degree Required
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Advanced Ophthalmology Technology Market to Hit Valuation of US$ 16.01 Billion by 2033
The market is rapidly advancing, driven by an aging population's needs. A clear segmentation is emerging hospitals focus on complex, high-margin procedures, while specialized centers increasingly absorb routine surgeries. Chicago, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The global advanced ophthalmology technology market was valued at US$ 8.78 billion in 2024 and is expected to reach US$ 16.01 billion by 2033, growing at a CAGR of 6.9% during the forecast period 2025–2033. The future of the advanced ophthalmology technology market is being written today in research labs and clinical trials around the world. A robust pipeline of innovative treatments, particularly in areas like gene therapy for inherited and chronic eye diseases, holds the promise of not just managing but potentially reversing vision loss. The intense research activity is also reflected in the continuous stream of new patents being filed, protecting the intellectual property that will form the basis of next-generation devices and therapies. This forward-looking activity, combined with a growing and specialized workforce, ensures a long-term trajectory of growth and transformative breakthroughs for the industry. Download Sample Pages: The scale of innovation is evident in patent and clinical trial data. In 2024 alone, 1,393 international patents related to vision science were published. Ophthalmic Sciences, an innovator in the field, holds 6 total patents, with 3 of those being active globally. The clinical trial landscape is equally vibrant. The RGX-314 gene therapy trial for wet AMD has enrolled 465 patients, while the SOL-R registrational trial for AXPAXLI in the same condition has a target randomization of at least 555 patients. A search on reveals 22 active clinical studies focused on gene therapy for wet AMD. Supporting this innovation is a skilled workforce; the mean number of ophthalmologists per 100,000 inhabitants across Europe is 9.36, with nations like Italy having 12.28 practicing ophthalmology physicians per 100,000 persons in 2024. Niche markets are also showing strong growth, with the U.S. dry eye treatment devices market reaching approximately $99.7 million in 2024 to serve the around 16 million people diagnosed with Dry Eye Disease. Key Findings in Advanced Ophthalmology Technology Market Market Forecast (2033) US$ 16.01 billion CAGR 6.9% Largest Region (2024) North America (39%) By Type Diagnostic (58%) By End Use Hospitals (41%) Top Drivers Rising prevalence of age-related eye diseases boosts technology demand. Continuous technological advancements are improving diagnostic and surgical outcomes. Growing patient awareness regarding the importance of early eye diagnosis. Top Trends Artificial intelligence integration is revolutionizing diagnostics and treatment planning. Increasing surgeon and patient preference for minimally invasive procedures. Shift of routine surgeries from hospitals to specialized outpatient centers. Top Challenges The high acquisition and maintenance costs of advanced ophthalmic technologies. A growing shortage of skilled ophthalmologists to operate new equipment. Complex reimbursement policies and stringent regulatory approval processes. Financial Titans Dominating the Global Advanced Ophthalmology Technology Market Landscape The financial health of key industry players provides a powerful indicator of the market's robust vitality and sustained growth potential. These leading companies are demonstrating exceptional performance through impressive sales figures and strong operational cash flows, reflecting the high demand for their innovative products. Their financial strength not only solidifies their market position but also enables continued investment in the research and development that drives the entire sector forward. A close examination of their financial reports reveals a clear and compelling narrative of a thriving and profitable industry, setting a confident tone for future expansion and shareholder value in a competitive environment. Alcon, a global leader in the advanced ophthalmology technology market, showcases remarkable financial strength, reporting total net sales of $9.8 billion for the full year 2024. The performance was robust across its divisions, with Surgical net sales reaching $5.5 billion and Vision Care net sales hitting $4.3 billion. The company achieved a record cash from operations of $2.1 billion and a record free cash flow of $1.6 billion. A breakdown of 2024 quarterly performance further illustrates this momentum: Q1 sales were $2.4 billion, with $341 million in cash from operations and $229 million in free cash flow. Q2 sales increased to $2.5 billion, with Surgical net sales at $1.4 billion and Vision Care sales reaching $2.2 billion in the first half. Q3 saw net sales of $2.4 billion, with the Surgical segment contributing $1.34 billion, and Q4 sales were $2.5 billion. Bausch + Lomb also posted strong full-year 2024 revenues of $4.791 billion, with its Surgical segment accounting for $843 million and generating $232 million in cash flow from operations for the year. The company's third quarter revenue was $1.196 billion, with the surgical segment at $206 million and cash flow from operations at $154 million, while Q4 surgical revenue was $231 million. Topcon's Eye Care business reported first-half fiscal year 2024 sales of ¥37.1 billion (€224 million), with a full-year revenue forecast of ¥82.0 billion (€495 million). The combined North American and European half-year sales for Topcon were approximately ¥60 billion, underscoring the strong international demand within the advanced ophthalmology technology market. Unprecedented Surgical Volumes Propel Growth in the Advanced Ophthalmology Technology Market The sheer volume of surgical procedures performed worldwide is a primary engine powering the expansion of the market. An aging global population and the increased prevalence of conditions like cataracts are driving millions of patients to seek surgical solutions. Simultaneously, the introduction of safer, faster, and more effective minimally invasive techniques has broadened patient acceptance and accessibility. The statistics on cataract, LASIK, and SMILE procedures paint a vivid picture of a sector experiencing immense procedural demand. Such high volumes necessitate a continuous supply of advanced surgical equipment, implants, and consumables, creating a powerful and self-reinforcing cycle of growth and innovation. By 2025, an estimated 28 million cataract surgeries are performed annually across the globe, which translates to roughly 75,000 procedures every single day. The minimally invasive refractive procedure, Small Incision Lenticule Extraction (SMILE), has already surpassed 10 million procedures performed worldwide as of the end of 2024 in the advanced ophthalmology technology market. Since its FDA approval in 2016, an average of more than 1 million people have chosen SMILE each year, a procedure now offered by over 2,000 surgeons in 70 countries. The demand for intraocular lenses (IOLs) is staggering, with a projected 200 million patients requiring IOL implantation by 2025. In the United States alone, approximately 800,000 LASIK procedures are performed annually. Growth is also pronounced in developing markets; the estimated cataract surgery rate in China is expected to reach 350 per 100,000 people by 2025. Illustrating global outreach efforts, one specific aid project in Cambodia has already provided free surgery to 3,138 cataract patients, highlighting the vast unmet need that technology can address. Next-Generation Diagnostic and Monitoring Tools Redefine Patient Care and Market Demand Early and accurate diagnosis is the cornerstone of effective ophthalmology, and advanced diagnostic equipment is at the forefront of advanced ophthalmology technology market. Technologies like Optical Coherence Tomography (OCT) have become indispensable, providing high-resolution, cross-sectional images of the retina that enable the detection and management of numerous sight-threatening diseases. The growing prevalence of conditions such as diabetic retinopathy and age-related macular degeneration (AMD) is directly fueling the demand for these sophisticated diagnostic platforms. The market is responding with increasingly powerful and user-friendly devices, including handheld and automated units, that are expanding access to high-quality care from specialized clinics to primary care settings. The adoption rate of these technologies is reflected in strong sales figures, with 18,700 handheld OCT units sold globally in 2023. The clinical utility is immense, with over 50 million diabetes-related OCT scans performed annually. The technology's application in the advanced ophthalmology technology market is even extending beyond human medicine, with over 500 veterinary OCT devices now in use for animal diagnostics. Industry leader Topcon has sold over 20,000 units of its Maestro OCT system globally as of late 2023, a testament to the device's popularity and reliability. The urgency for such advanced diagnostic capability is underscored by daunting projections; approximately 200 million individuals are expected to be affected by AMD by the year 2040, creating a massive patient population in need of vigilant monitoring. Premium Intraocular Lenses Signal a Paradigm Shift in Cataract Surgery Outcomes The intraocular lens (IOL) segment has evolved far beyond simple vision correction, entering an era of premium technology that offers patients a range of lifestyle-enhancing benefits. Today's advanced IOLs can correct presbyopia, astigmatism, and other refractive errors, often reducing or eliminating a patient's dependence on glasses after cataract surgery. This shift towards premium, high-performance lenses represents a significant value-add in the cataract surgery space, driving revenue growth and patient satisfaction. As patient expectations rise, so does the demand for technologies that deliver superior visual outcomes, making the premium IOL sector a key growth area within the advanced ophthalmology technology market. The market's scale is substantial, with annual IOL lens unit shipments reaching 42 million in 2023, corresponding with the roughly 25 million cataract surgeries performed that year. The procedural efficiency in modern clinics further fuels this demand. High-volume cataract clinics now see surgeons implanting an average of 1,200 lenses per year. At an institutional level, surgical centers are now performing an average of 4,500 cataract cases annually. These high procedural volumes, combined with the increasing adoption of premium IOL technologies, create a powerful economic engine that supports ongoing innovation in lens design, materials, and functionality. Robust Investment and Venture Capital Fueling Future Ophthalmic Technology Market Breakthroughs A vibrant ecosystem of investment is crucial for nurturing the next wave of innovation, and the ophthalmology sector is attracting significant capital from diverse sources. Major corporations in the advanced ophthalmology technology market are channeling billions into research and development, while a dynamic venture capital landscape is providing essential funding for startups and emerging technologies. This influx of capital is accelerating the development of groundbreaking therapies, more advanced surgical devices, and sophisticated software platforms. The high level of merger and acquisition activity further signals a mature and attractive market where proven innovations are being rapidly integrated into larger commercial platforms, promising a future rich with transformative solutions. The financial commitment to innovation is clear. Alcon's R&D investment for the twelve months ending March 31, 2025, stood at an impressive $899 million, with annual R&D expenses for 2024 totaling $876 million. Across the industry, total investment in ophthalmology in 2024 exceeded $6.3 billion. The market also saw 18 merger and acquisition transactions in 2024, indicating strong consolidation and strategic growth activity. The venture capital pipeline is equally robust, with financing in ophthalmology for the first quarter of 2025 reaching $515.7 million across 21 transactions. As of May 2025, U.S. ophthalmology companies had already raised $597 million in equity funding through 15 rounds. Looking at a longer trend, the total venture capital investment in the ophthalmic devices sector over the last 10 years has amounted to a formidable $2.51 billion. Artificial Intelligence Integration Revolutionizes Diagnostics in the Advanced Ophthalmology Technology Market Artificial intelligence (AI) is rapidly transitioning from a theoretical concept to a practical and powerful clinical tool within the market. AI algorithms are now capable of analyzing retinal images with remarkable speed and accuracy, detecting early signs of diseases like diabetic retinopathy long before they might be caught by traditional methods. This technology is democratizing access to specialist-level diagnostics, enabling screening to be performed in primary care settings and reducing the burden on ophthalmologists. The efficiency and precision of AI are not just improving patient outcomes but also creating new operational efficiencies for healthcare systems. The real-world adoption of AI is accelerating in the advanced ophthalmology technology market. As of mid-2024, 198 AI-equipped cameras have been deployed across five U.S. health systems, covering a population of approximately 151,000 patients with diabetes. In the United States, three FDA-approved AI algorithms for diabetic retinopathy screening were available as of 2025. The clinical uptake is evident in reimbursement data, with more than 15,000 Medicare claims filed for AI diabetic retinopathy screening algorithms since 2022. The efficacy of these systems was proven in a clinical trial involving 900 patients, which led to FDA approval for one AI eye exam system. The speed of these platforms is a key advantage; scans using the AEYE-DS diabetic retinopathy algorithm are designed to produce actionable results in under 60 seconds. Surgical Laser Precision and Speed Setting New Benchmarks for Ophthalmic Procedures Modern excimer and femtosecond lasers are the technological cornerstones of refractive and cataract surgery, and continuous innovation is pushing the boundaries of what is possible in the advanced ophthalmology technology market. Today's surgical laser platforms offer unparalleled precision, speed, and safety, enabling surgeons to perform highly customized and predictable procedures. Advancements in eye-tracking technology, laser pulse frequency, and treatment algorithms are leading to better visual outcomes, faster recovery times, and an enhanced patient experience. These technological leaps are critical for meeting the high expectations of patients seeking freedom from corrective eyewear and are a major factor in the continued growth of the refractive surgery market. The Bausch + Lomb TENEO Excimer Laser Platform exemplifies this cutting-edge technology with its impressive performance metrics. The platform boasts an exceptionally fast ablation time of approximately 1.2 seconds per diopter, minimizing procedure time and improving patient comfort. Supporting this speed is an advanced eye-tracker that operates at an incredible 1,740 Hz, ensuring the laser remains perfectly centered on the eye even with involuntary movements. The TENEO laser itself operates at a high speed of 500 Hz, allowing for swift and highly precise corneal tissue ablation. These specific, quantifiable advancements are what define the leading edge of the advanced ophthalmology technology market, delivering tangible benefits to both surgeons and patients. Customize the Data Scope to Match Your Objectives: Strategic Private Equity Investment and Remote Care Reshape Ophthalmic Service Delivery The business landscape of ophthalmology is being actively reshaped by two powerful forces: strategic investment from private equity and the rise of remote care models. Private equity firms are increasingly drawn to the sector's stable growth and opportunities for consolidation, leading to a wave of practice acquisitions. This trend is creating larger, more efficient practice groups with greater resources for technology adoption. In parallel, tele-ophthalmology platforms are gaining traction, leveraging technology to conduct remote eye exams and consultations. This remote care model is expanding access to services, particularly in underserved areas, and creating new, flexible models for delivering eye care. The impact of private equity is significant in the advanced ophthalmology technology market, with over 330 private equity-backed physician practice management (PPM) transactions recorded in ophthalmology over the last five years. This consolidation trend is fundamentally changing the structure of service delivery in the market. Simultaneously, the telehealth revolution is making its mark. The remote examination platform from DigitalOptometrics, for instance, has already conducted over 2 million remote exams. This number highlights a clear and growing acceptance of remote technologies by both patients and providers, signaling a permanent shift in how ophthalmic services can be delivered and scaled. Global Advanced Ophthalmology Technology Market Major Players: Alcon Allergan Bausch + Lomb Carl Zeiss Meditec EssilorLuxottica Heidelberg Engineering HOYA Johnson Johnson Vision NIDEK CO., LTD Novartis Ophthotech Corporation Regeneron Pharmaceuticals, Inc. Roche Samsung Topcon Other Prominent Players Key Market Segmentation: By Type Diagnostic Therapeutic By End Use Hospitals Ambulatory Surgical Centers (ASCs) Ophthalmic Clinics Others By Region North America Europe Asia Pacific Middle East & Africa South America Explore the Report Before You Buy – Book a Walkthrough: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 minutes ago
- Yahoo
Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday
Health care stocks were flat to higher premarket Tuesday, with the iShares Biotechnology ETF (IBB) i Sign in to access your portfolio
Yahoo
12 minutes ago
- Yahoo
A Timeless Wedding With a Black and White Color Palette at Charlotte's Mint Museum
The couple tied the knot a few years earlier, so they planned a wedding that allowed them to celebrate with all of their loved ones. Ashley Appiagyei and Michael Cole met on a dating app in April of 2018. At the time, Ashley was in her last year of medical school and Michael was teaching middle school science in Charlotte. 'We both immediately felt comfortable with each other and ended up talking for almost four hours,' Ashley says. After that, their conversation never ebbed. The duo found themselves spending every day together that week, so it came as little surprise to either when a relationship naturally formed. Two years later, in October of 2020, Michael proposed at a secluded fountain during a trip to Puerto Rico. Ashley and Michael tied the knot in private during the pandemic, but they were thrilled to invite 250 guests to join them for the official party a few years later. The couple decided to celebrate their love with a a black-tie wedding on September 3, 2023, at the Mint Museum in Charlotte, North Carolina. 'Even though we went with a black-tie affair for our wedding, we still wanted to capture a sense of ease and fun,' Ashley notes. 'The Mint Museum is a gorgeous venue in Uptown Charlotte that has a magnificent view of the Charlotte skyline which our guests got to enjoy all night long.' With help from Evelyn Kibwana from Evelyn Events, Ashley and Michael threw a classic, elegant celebration with a black and white color palette. 'As soon as we met her, we instantly connected, and felt reassured that she would handle all the complexities with the wedding,' Ashley says of the spark the duo felt with their planner. Here, every timeless detail from the couple's wedding celebration, as documented by Casey H Photos. Related: How to Renew Your Wedding Vows: Your Ultimate Guide to Planning a Meaningful Celebration Since they waited years to celebrate with all of their loved ones, Ashley and Michael made sure to throw all of the events they wanted. The weekend kicked off with a rehearsal dinner and a cultural wedding celebration. Ashley wore a gold beaded dress with a corset bodice and mermaid skirt while Michael wore a white and gold outfit. The couple and their guests also took part in a money dance. Ashley spent two full weeks shopping for her wedding dress. 'I knew I wanted something form fitting but otherwise was very open when it came to styles,' she explains. When she tried on a strapless mermaid wedding dress with detachable sleeves from Anne Barge in a Boston salon, she knew it was the one. 'I immediately felt glamorous and beautiful, and could imagine all the beautiful photos that I would get to look at for the rest of my life in that dress,' she remembers. The bride finished her look with a cathedral length veil from Etsy and drop earrings. She wanted her dress to be the focal point, so she kept her makeup look simple and went with an updo hairstyle. Ashley held a cascading bouquet of white flowers and greenery, including calla lilies, orchids, and roses. 'Created by CLUX and we were going with an elaborate, eye-catching effect with its flowing, waterfall-like design,' the bride notes. Michael wore a black tuxedo from Generation Tux, which he paired with Buffalo Bills cufflinks (he's a big fan!). The couple had a first look before the ceremony and took photos at the Mecklenburg County District Attorney's office with their son, Oliver. That morning, Ashley's brother, Osei, was on duty to get their one and a half year old son, Ollie, ready for the wedding. When they couldn't find his black dress shoes, they spent the afternoon running around the city looking for new shoes. 'Turns out it is not that easy to find black toddler dress shoes at the last minute!' Michael says. One of the couple's favorite memories of the day was taking photos with their son, who was barefoot but full of celebratory energy. Related: How to Incorporate a Newborn Baby Into Your Wedding The couple chose to emphasize the beauty of the museum during their ceremony. Rows of white chairs were set for guests to sit in as they watched the couple exchange vows. The aisle was lined with floating candles in glass hurricanes and arrangements of baby's breath placed on tall black pillars. When the ceremony began, Michael made his entrance with Ollie before Ashley walked down the aisle with her parents. The couple chose 'Lovely Day' by Bill Withers for the processional. Ashley and Michael enlisted their mothers to help with a handfasting ceremony, where their hands were symbolically tied together. Then, they exchanged vows they wrote for each other. 'Mike's vows were about four pages long and I kept mine short and sweet,' Ashley says. In keeping with the celebration's black and white color palette, the reception tables were dressed in white linens and paired with black chairs. The centerpieces included low white floral arrangements of hydrangeas and roses, tall baby's breath arrangements in black vases, and candles at various heights. The place settings featured black-rimmed chargers, black and white custom place settings, and matching menus. Ashley and Michael shared their first dance to 'When You Love Someone' by Lukas Graham. After, the bride and her dad danced to 'Dance With My Father' by Luther Vandross and Michael shared a dance with his mom to 'Mama' by Boyz 2 Men. For dessert, guests dug into slices of the couple's four-tiered wedding cake, which was decorated with a textured design in the buttercream icing and white flowers. 'We went with an all-white-on-white wedding cake which is the epitome of elegance and sophistication,' Ashley says. 'The goal was to create a stunning visual statement, offering a timeless and classic appeal.' They chose vanilla bean cake with chocolate decadence filling, red velvet cake with cream cheese filling, and chocolate fudge cake with peanut butter cup filling. After the wedding was over, the couple spent their honeymoon in Ochos Rios, Jamaica. To other duos planning a wedding, Ashley has some advice: 'Give yourself some cushion room if you can, because things always cost more than you originally think,' she says. 'We initially thought we wanted something simple, but once we started visiting venues and vendors, we realized that all the things we liked were much more expensive than we realized!" Real Weddings Credits Wedding Photographer Casey H Photos Wedding Planning and Design Events by Evelyn Wedding Venue Mint Museum Bride's Hair Jas'd Up by Jasman Bride's Makeup Terri Craft Rodgers Flowers and Rentals CLUX Invitations and Paper Products Minted Music Cool Receptions Catering Best Impressions Caterers Cake Cake Expressions by Lisa Transportation CLT Limo Bus Videographer Moving Mountains Up Next: Wedding Budget Breakdown: Here's How to Allocate Your Entire Wedding Budget Read the original article on Brides Solve the daily Crossword
